Vanguard Group’s Immix Biopharma IMMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Hold |
698,537
| – | – | ﹤0.01% | 3643 |
|
|
2025
Q1 | $1.17M | Hold |
698,537
| – | – | ﹤0.01% | 3664 |
|
|
2024
Q4 | $1.54M | Hold |
698,537
| – | – | ﹤0.01% | 3639 |
|
|
2024
Q3 | $1.04M | Buy |
698,537
+100,000
| +17% | +$149K | ﹤0.01% | 3764 |
|
|
2024
Q2 | $1.19M | Buy |
598,537
+142,351
| +31% | +$282K | ﹤0.01% | 3735 |
|
|
2024
Q1 | $1.4M | Buy |
456,186
+295,788
| +184% | +$908K | ﹤0.01% | 3704 |
|
|
2023
Q4 | $1.11M | Buy |
160,398
+54,188
| +51% | +$375K | ﹤0.01% | 3794 |
|
|
2023
Q3 | $363K | Buy |
106,210
+853
| +0.8% | +$2.92K | ﹤0.01% | 4146 |
|
|
2023
Q2 | $283K | Hold |
105,357
| – | – | ﹤0.01% | 4251 |
|
|
2023
Q1 | $192K | Hold |
105,357
| – | – | ﹤0.01% | 4325 |
|
|
2022
Q4 | $241K | Buy |
105,357
+232
| +0.2% | +$531 | ﹤0.01% | 4271 |
|
|
2022
Q3 | $143K | Buy |
105,125
+54,220
| +107% | +$73.8K | ﹤0.01% | 4461 |
|
|
2022
Q2 | $132K | Buy |
+50,905
| New | +$132K | ﹤0.01% | 4517 |
|